SALT LAKE CITY, April 15, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corp. (Nasdaq:BSDM) today reported on clinical data presented by Rudiger Wessalowski, M.D, Associate Professor at the Clinic of Pediatric Hematology and Oncology, Heinrich-Heine University, Dusseldorf, Germany, on the use of hyperthermia combined with chemotherapy and tumor resection to treat malignant germ cell tumors in children and adolescents. Dr. Wessalowski presented an update of his clinical study at the annual Society for Thermal Medicine (STM) meeting that was held in Tucson, Arizona on April 4 to April 7, 2009.
